Roivant Sciences Ltd. reported an insider ownership change by Matthew Gline involving the company’s common shares on June 30, 2026. The filing reflects the withholding of 76,171 common shares at a reported price of $35.39 per share, representing an aggregate value of approximately $2.70 million. The transaction was tied to the vesting and settlement of restricted share units, or RSUs, previously granted to Gline. According to the explanatory note, Roivant “net settled” the RSUs by withholding shares to satisfy applicable tax withholding obligations. This type of transaction is generally reported on Form 4 under transaction code “F,” indicating shares surrendered or withheld by the issuer for tax purposes rather than an open-market sale. Because the shares were withheld by Roivant in connection with RSU settlement, the filing does not necessarily indicate a discretionary sale by the insider. Instead, it reflects an administrative disposition of shares to cover taxes triggered when the RSUs vested. The provided filing text does not state the number of shares Gline continued to beneficially own after the transaction, and no additional remarks were included beyond the tax-withholding explanation.